QF
ASMB icon

QVT Financial’s Assembly Biosciences ASMB Stock Holding History

QVT Financial’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,440
Closed -$1.86M – 63
2017
Q3 		$1.86M Sell
4,440
-28,267
-86% -$8.66M 0.07% 60
2017
Q2 		$7.67M Sell
32,707
-25,194
-44% -$7.1M 0.2% 43
2017
Q1 		$15.6M Sell
57,901
-8,065
-12% -$1.98M 0.49% 30
2016
Q4 		$8.18M Sell
65,966
-1,334
-2% -$198K 0.25% 49
2016
Q3 		$5.06M Hold
67,300
– – 0.19% 58
2016
Q2 		$3.74M Buy
67,300
+5,575
+9% +$366K 0.26% 62
2016
Q1 		$3.05M Buy
61,725
+17,142
+38% +$1.15M 0.19% 74
2015
Q4 		$3.62M Hold
44,583
– – 0.2% 72
2015
Q3 		$5.12M Hold
44,583
– – 0.18% 66
2015
Q2 		$10.3M Hold
44,583
– – 0.16% 60
2015
Q1 		$7.08M Hold
44,583
– – 0.39% 57
2014
Q4 		$3.87M Buy
+44,583
New +$4.39M 0.19% 78

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

QVT Financial's ASMB Position: Q4 2017 in Review

QVT Financial sold out of Assembly Biosciences (ASMB) in Q4 2017, closing a stake of 4,440 shares — an estimated $1.86M sold.

QVT Financial first reported a position in ASMB in Q4 2014 and held it in 12 quarters. The position peaked at $15.6M in Q1 2017. 98 funds tracked by Wall St. Rank hold ASMB as of Q4 2017.

  • QVT Financial reported no remaining Assembly Biosciences position as of Q4 2017 after selling out during the quarter.
  • QVT Financial sold 4,440 Assembly Biosciences shares in Q4 2017, an estimated $1.86M.
  • QVT Financial first reported a position in Assembly Biosciences in Q4 2014 and held it in 12 quarters.
  • QVT Financial's Assembly Biosciences position peaked at $15.6M in Q1 2017.
  • 98 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2017.

Based on QVT Financial's 13F filing for Q4 2017, filed 14 Feb 2018.